Articles From: Commerce Bank Introduces the National Association of Social Workers Visa® Rewards Credit Card to CytoCore to Acquire MEDITE

The National Association of Social Workers (NASW) and Commerce Bank have come together to offer NASW members a Visa ® rewards credit card.
Sign-up for Commerce Bank Introduces the National Association of Social Workers Visa® Rewards Credit Card investment picks
Sign-up for Conatus Pharmaceuticals Updates Development Strategy and 2014 Milestones investment picks
Agreement represents continued movement forward in the development of a potential new treatment for rare cancers TORONTO and BANNOCKBURN, Ill.
Sign-up for Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma investment picks
Financial advisors see anxiety adversely impacting clients’ financial planning and investment decisions, according to survey results released today by Hartford Funds .
Sign-up for Consumer Anxiety Adversely Impacts Financial Planning and Investment Decisions, Hartford Funds Survey Finds investment picks
Sign-up for Consumers Energy Advises Winter Visitors to Its 13 Hydroelectric Plants to Exercise Extreme Caution investment picks
Continental AG (CON.XE) said Monday it is aiming for a sales increase of around of 5% this year after sales climbed in 2013, despite negative currency effects.
Sign-up for Continental AG Sees Further Growth After 2013 Sales Rise investment picks
Insignia Systems, Inc. (ISIG) today announced that it has surpassed fifty million signs as part of its Insignia POPS ® Program.
Sign-up for Continued Success with Laser Die Cut Drives Insignia Past 50 Million Mark investment picks
Cooper Tire & Rubber Company (NYSE: CTB) today issued the following statement regarding the status of financial and operational data entry at its Cooper Chengshan (Shandong) Tire (CCT) joint venture facility in Rongcheng, China.
Sign-up for Cooper Tire Updates Status of Financial and Operational Data Entry at Chinese Joint Venture investment picks
Sign-up for Copa Holdings Announces Monthly Traffic Statistics for December 2013 investment picks
Sign-up for Core Lab Announces Q1 2014 Quarterly Dividend; Increases Quarterly Dividend By 56.25% To $0.50 Per Share investment picks
By Luciana Magalhaes BELO HORIZONTE, Brazil--Argentine billionaire Eduardo Eurnekian on Monday wrapped up negotiations to purchase a stake in a Brazilian semiconductor venture from financially-stricken Brazilian entrepreneur Eike Batista, according to the Minas Gerais state government.
Sign-up for Corporacion America Buys Eike Batista's Stake in Semiconductor Firm investment picks
Sign-up for CORRECTING and REPLACING -- Noodles & Company Announces Preliminary Results for Fourth Quarter 2013 investment picks
"Celgene Raises Estimates For 2013" at 12:13 pm ET misstated the previous 2013 per-share adjusted earnings guidence in the fourth paragraph.
Sign-up for Correction to Celgene Raises Estimates Story investment picks
"Five Chinese Firms Halt China IPO As Beijing Tightens IPO Supervision --Update," published at 1152 GMT, incorrectly reported that drug maker Jiangsu Aosaikang Pharmaceutical Co.
Sign-up for Correction to Five Chinese Firms Halt China IPO Update investment picks
Costamare Inc. (the “Company”) (NYSE:CMRE) announced today that its offering of 4,000,000 shares of its 8.50% Series C Cumulative Redeemable Perpetual Preferred Stock, par value $0.0001 per share, liquidation preference $25.00 per share (the “Series C Preferred Stock”), was priced at $25.00 per share.
Sign-up for Costamare Inc. Announces Pricing of its 8.50% Series C Preferred Stock investment picks
CHONGQING, China , Jan.
Sign-up for Country Style Cooking Restaurant Chain Announces Preliminary Fourth Quarter 2013 Results investment picks
2014/1/13 PHILADELPHIA, PA --
Sign-up for Courtyard Hotel to Open at Philadelphia Navy Yard investment picks
Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one in Brazil and the other in China – that will enable it to help better meet the specific needs of underserved ‘value segment’ markets.
Sign-up for Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’ investment picks
Sign-up for Covisint Corporation Announces Third Quarter Fiscal 2014 Earnings Release Date and Conference Call investment picks
CSR plc (LSE: CSR; NASDAQ: CSRE) today announces it has joined the Mopria Alliance as an executive member.
Sign-up for CSR Joins the Mopria Alliance as an Executive Member investment picks
SAN DIEGO, Calif., Jan.
Sign-up for Cubic Empowers Employees to Reduce Home Energy Use investment picks
Cubist Pharmaceuticals, Inc .
Sign-up for Cubist Announces Fourth Quarter/Full-Year 2013 Revenues; Provides Pipeline Update investment picks
Sign-up for Curtiss-Wright Acquires Component Coating and Repair Services Limited investment picks
Research confirms long-held industry standard for optimal medication adherence and finds moderate levels of adherence demonstrated no protective benefit WOONSOCKET, R.I. , Jan.
Sign-up for CVS Caremark Research Finds Optimal Adherence to Medications Prescribed Post-Heart Attack Reduces Hospital Readmissions investment picks
CyberOptics Corporation (Nasdaq: CYBE) today reported that it expects to report sales of $8.2 to $8.6 million for the fourth quarter of 2013 ended December 31, exceeding the previously issued sales guidance of $7.0 to $8.0 million for this period due primarily to above-plan sales of SMT inspection systems.
Sign-up for CyberOptics Issues Preliminary Fourth Quarter 2013 Operating Results and 2014 Outlook investment picks
CyberOptics Corporation (Nasdaq:CYBE) will make an investor presentation at the 16 th Annual Needham & Company Growth Conference on January 16, 2014.
Sign-up for CyberOptics To Present at Needham Growth Conference on January 16 investment picks
Sign-up for CYREN to Present at January Investment Conferences investment picks
2014/1/13 ORLANDO, FL and CHICAGO, IL --
Sign-up for CytoCore to Acquire MEDITE investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Commerce Bank Introduces the National Association of Social Workers Visa® Rewards Credit Card to CytoCore to Acquire MEDITE
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity